Skip to main content
Search
< All Topics
Print

Jeffrey Epstein’s Reproductive History: Hormones, Genetics, Fertility Treatment and Paternity Claims

Updated
ByEpsteinWiki

Snapshot

Jeffrey Epstein’s reproductive history contains documented hormone problems, sperm storage arrangements, personal genome research, support for other people’s fertility treatment, requests that women bear his children, and unresolved fatherhood claims. The records reviewed do not establish lifelong sterility or identify a child whose biological paternity has been reliably verified as his.

The story is one of overlapping ambitions and unresolved outcomes. He struggled with hormone treatment, helped other people pursue parenthood, preserved his own biological material and entertained proposals for genetically engineered children. The strongest new records reach beyond an abstract fascination with DNA: they include an optional proposal to edit his cells and a specific 2018 designer baby funding discussion. The documented steps still stop short of proving a child born from his sperm or an implemented reproductive program.

His emotional history is less certain. His correspondence records frustration with treatment and its effects on his body and thinking. Other people describe reproductive promises, generosity, controlling demands and ambitions to perpetuate his DNA. These accounts support investigation of how he understood reproduction, masculinity and legacy. They do not establish that infertility, genital appearance or resentment caused his abuse.

Scope: Public records and reporting reviewed through September 30, 2026. A lifelong chronology necessarily includes gaps. No continuous reproductive medical history from childhood to death has been identified.

What the Evidence Can Establish

QuestionStrongest evidence reviewedPresent conclusion
Did he have low testosterone?Laboratory results and treatment correspondenceYes, at documented times.
Was he permanently sterile?No conclusive semen analysis or permanent sterility diagnosis identifiedNot established.
Did he arrange sperm storage?Cryobank correspondence, forms and signed contractYes. Subsequent use and present inventory remain unresolved.
Did he pursue research on his own genome?Emails about sequencing, skin samples and cell culturesYes. This does not establish reproductive cloning.
Did he help others obtain fertility treatment?Indyke and Groff accounts, Kahn correspondence, egg freezing emailsDocumented in several accounts and communications, with differing levels of verification.
Did women report requests to bear his child?Sjoberg’s deposition and Giuffre’s accountYes. A request does not establish conception or birth.
Did women report egg procurement?Bryant’s account and a reported offer to Audra LynnYes, with substantial differences between an offer, suspected procedure and verified retrieval.
Did he father children?Conflicting statements, allegations and unidentified DNA testing recordsNo reliably verified child identified in this review.
Did reproductive difficulties cause misogyny or a psychological collapse?No direct causal evidence identifiedA hypothesis, not an established finding.

The Lifelong Chronology

PeriodReproductive evidenceQualification
Childhood through early adulthoodNo developmental reproductive records identifiedPuberty, congenital conditions and early fertility remain unknown.
Late 1990sMaxwell later described testosterone patches and discussions of having a childRetrospective account, not a contemporaneous fertility diagnosis.
Early 2000sReported requests to women to bear children; later reporting describes genetic legacy discussionsDates and sourcing vary. No resulting birth is established.
By 2007Defense submissions described fertility assistance to employeesFavorable character evidence requires attribution.
2009Kahn thanked him for IVF support; paternity test instructions and a DNA exclusion report appear in correspondenceThe DNA report does not identify its sample donors.
2010Total testosterone measured at 188 ng/dLBelow the laboratory range, not proof of sterility.
2012IVF research correspondence and cryobank renewal messageDifferent people and purposes must not be merged.
2013 and 2014Skin cell cultures, genome research and sequencing payment arrangementsActual biological research, not evidence of a cloned child.
2015 and 2016Low testosterone discussions, testicular hypofunction coding, clomiphene complaints and sperm banking paperworkHormonal treatment and reproductive capacity are separate questions.
2016 through 2018Egg freezing discussions, funding offers, hormone reports and anticipated retrievalNo demonstrated link to fertilization with Epstein’s sperm.
2019Prison intake records his statement that he had no children; an FBI witness recalled an earlier fatherhood claimContradictory accounts without independent paternity verification.
After his deathEstate inquiries, civil allegations, additional files and reporting about stored biological materialClaims and storage documents do not establish surviving offspring.

Testosterone and Testicular Function

The March 2010 laboratory report records total testosterone of 188 ng/dL against a reference range of 250 to 1,100. Free testosterone was 36.5 pg/mL against a range of 35 to 155. FSH and LH were within the listed ranges. This is direct evidence of a low total testosterone result, with free testosterone near the bottom of its range. It contains no sperm count or motility result.

Bruce Moskowitz’s August 18, 2014 email reported that Epstein’s testosterone was still low, at 142. Moskowitz’s October 6, 2017 email reported 125. Neither short message supplies units, a reference range or specimen collection conditions. These physician reports extend the chronology without establishing an uninterrupted decline.

The January 2016 BioReference laboratory packet complicates any claim that his testosterone was uniformly low. The preliminary report, at stamp EFTA00599646, records a specimen collected January 27 with total testosterone of 296.0 ng/dL against a range of 193 to 740 and free testosterone of 80.18 pg/mL against 30 to 150. Its October 27, 2015 comparison values, 112.3 and 29.82 respectively, were flagged low. The January values were within that laboratory’s ranges. Neither result measures sperm production.

The April 2015 correspondence records Epstein describing low testosterone for approximately 15 years, hesitancy about a treatment regimen and a reported value of 138. Jeffrey Mechanick had recommended AndroGel. The value of 138 is reported in an email rather than independently verified here from its original laboratory sheet. His estimate places the problem around 2000, but cannot establish its exact onset.

Harry Fisch’s October 2015 form marks “Testicular Failure,” code 257.2, associated with testicular hypofunction. The listed boxes for azoospermia, male infertility and vasectomy are not marked. A checked endocrine diagnosis should not be expanded into a diagnosis of complete absence of sperm.

The July 2016 urology form marks chronic prostatitis. It likewise does not mark the listed infertility, azoospermia or vasectomy diagnoses. This supports a history of another urological problem, without resolving whether he could father a child.

The June 24, 2016 specimen report records total testosterone of 149 ng/dL against a range of 250 to 827, at stamp EFTA00606969. The September 8, 2016 report records total testosterone of 153 ng/dL against 348 to 1,197, at stamp EFTA00287156. Its free plus weakly bound result of 48.3 ng/dL was within the stated range of 40 to 250. That measurement must not be confused with free testosterone alone.

The August 9, 2017 specimen report records total testosterone of 197 ng/dL against 250 to 827, at stamp EFTA00621384. The August 14, 2018 laboratory result records 150 ng/dL against the same range, at stamp EFTA00314228. These immunoassay reports caution about accuracy at low concentrations and recommend a different method in that setting. Different reference intervals and measurement methods belong beside the numbers. The accumulating record supports recurrent low total testosterone while preserving the documented variability.

Could He Have Been Sterile?

The AUA and ASRM male infertility guideline explains a relevant medical distinction: testosterone supplied from outside the body can suppress the hormonal signals supporting sperm production, sometimes to the point of azoospermia. Drugs such as clomiphene can instead stimulate endogenous testosterone production in selected circumstances. These mechanisms explain why his treatment history matters. They do not tell us what happened to his sperm production.

Low testosterone, difficulty obtaining an erection, ejaculation, sperm quality and ability to father a child cannot be treated as interchangeable findings. Nor would a low testosterone result in 2010 prove that he had been unable to conceive a child in the 1980s or 1990s.

The semen PCR records concern testing for organisms. A further semen PCR report addresses the same kind of laboratory question. These are not the semen analyses needed to establish sperm concentration, motility or reproductive prognosis. Correspondence about transporting a sperm PCR sample from Florida likewise does not establish a cryobank transfer.

The July 21, 2017 vasectomy webpage email contains a link to a urology practice’s appointment webpage. The visible document identifies no patient, booked date, operation or subsequent semen clearance test. It is a lead to investigate, not a confirmed vasectomy history.

The records leave open several possibilities, including reduced fertility at particular times or treatment related suppression. They do not support a finding of permanent lifelong sterility. A properly attributed semen analysis, operative record, physician assessment or verified biological child would materially change this conclusion.

The July 31, 2016 exchange with Jay Lombard records Epstein reporting negative urine cultures, a semen finding abbreviated as “gc,” and treatment with ceftriaxone and azithromycin. He also described a diminished urine stream and testosterone of 125 that he said had remained similar for ten years. This is a patient’s account to a doctor, not a gonorrhea positive blood test report or a decade of measured hormone values. Lombard suggested testing for a possible C1 inhibitor deficiency; the suggestion was not a diagnosis. The original laboratory finding and its effects on fertility remain unresolved.

His Feelings About Hormone Treatment

The October 2015 treatment discussion places Fisch, Mechanick and clomiphene within his medical correspondence. The December 2015 message records a headache after four days of clomiphene.

The February 2016 email chain contains stronger emotional evidence. Epstein said he felt better after stopping Clomid and described water retention, changes around his waist, feeling “as if pregnant” and feeling “STUPID.” He regarded the treatment as a major mistake. These are his reported experiences, not a clinical determination that the drug caused every symptom.

Peter Attia’s February 9, 2016 lab summary reported testosterone increasing from 159 to 313 and free testosterone from 4.08 to 7.6, without printing units. The associated Clomid exchange records Epstein confirming that the tests were obtained while on treatment. This places a reported biochemical improvement alongside his distinctly negative account of how the treatment felt. Laboratory response and tolerability were different parts of his experience.

The August 2016 correspondence continues discussion of testosterone replacement and clomiphene. Taken together, the messages show persistent attention to treatment and dissatisfaction with particular effects on his body and cognition.

They do not record a clear admission of infertility, grief over being unable to father children, or hostility toward women caused by reproductive failure. The closest direct evidence concerns frustration with treatment. An interpretation involving wounded pride or reproductive anxiety should remain explicitly interpretive.

The April 20, 2016 exchange with Fisch adds a disagreement about cause. Epstein reported triglycerides of 750 and said he had stopped the treatment, referring sarcastically to a miracle cure. Fisch considered Clomid unlikely to explain the increase but agreed that stopping and observing was reasonable. The physician’s reply should not disappear behind Epstein’s complaint. Because both February and April messages describe stopping, the exact pattern of dosing and any resumption remains uncertain.

Reports About His Penis and the Contrary Autopsy Description

The September 2, 2009 deposition transcript records attorney Spencer Kuvin asking about an “egg-shaped penis.” Kuvin then referred to a witness description in a police probable cause affidavit. Epstein’s lawyers objected and ended the deposition. Epstein did not provide a substantive answer confirming the description.

The associated discovery dispute includes arguments about photographing his genitalia. His lawyers described the questioning and proposed inspection as humiliating and irrelevant. These are litigation positions. They establish opposition to the questioning, not Epstein’s private emotional response or a medical diagnosis.

Tina Brown’s November 2025 interview with Rina Oh reports Oh describing an unusually small, lemon shaped erect penis. Oh also offered an interpretation of its importance to his behavior. Her recollection and her psychological interpretation should be attributed separately. Neither is a specialist examination.

The August 11, 2019 autopsy, at page stamp EFTA00130078, describes his genitalia as “atraumatic and of a normal, circumcised man.” This is significant contrary medical evidence and belongs beside the witness descriptions. The external examination was not an assessment of erections, intercourse or sperm production.

The accounts cannot be resolved into a confirmed anatomical disorder from these materials. No diagnosis of micropenis, Peyronie’s disease or a congenital syndrome is established here. Genital appearance alone would not prove infertility, and it cannot explain or excuse sexual abuse.

Radar’s February 2026 enlargement article adds a claim that requires a different kind of source check. The May 1, 2012 Dr. MaxMan email is generic product advertising, with a redacted recipient and promotional claims about a herbal enhancement formula. It contains no personalized medical consultation, request from Epstein, reply, purchase or evidence of use. Receiving or retaining an advertisement does not establish that he sought enlargement treatment, and the advertisement supplies no anatomical diagnosis.

Maxwell, Marriage and Promises of a Child

The October 2019 defense proffer summarized in a prosecution memorandum, at stamps EFTA02731143 and EFTA02731144, is central to the relationship chronology. Maxwell’s counsel represented that she wanted marriage and a child in the late 1990s. Epstein would not marry her but agreed to a child, according to that account, and the prospect helped keep her in the relationship.

The handwritten proffer notes also record her account of testosterone patches around 1997 or 1998 and behavioral changes she associated with them. These are versions of the same account, not independent corroboration. A medical condition discussed in this portion of the proffer belongs to Maxwell; it must not be reassigned to Epstein or automatically described as infertility.

Bloomberg reported Maxwell coordinating semen samples with Epstein in late 2005 and on September 19, 2007. No treatment outcome is established.

Maxwell’s 2025 interview, including stamp EFTA02847154, revisits patches and his claimed erectile problem. She expressed later doubt about his explanation. Her accounts therefore support a reported history of hormone use and reproductive promises, while retaining uncertainty about his sexual function and truthfulness.

A witness preparation memorandum records a witness’s belief that Maxwell appeared pregnant in a photograph. Juan Alessi’s preparation memorandum records that he never saw her pregnant. Neither establishes a pregnancy, a birth or Epstein’s paternity.

Maxwell’s October 2013 bank statement adds a separate lead: a $1,000 transaction described as “Nyu School of Med Ivf.” The statement associates the merchant transaction with October 21, within an October 22 posting entry. It does not identify the patient or purpose, and is not proof that Maxwell underwent IVF or conceived with Epstein.

The proposed child can reasonably be examined as a relationship promise. The suggestion that it was deliberately used to retain Maxwell is supported by the account presented through her counsel, rather than independently established from a contemporaneous agreement.

His Own Sperm Storage Arrangements

The October 2012 cryobank renewal correspondence shows storage related communication addressed to Epstein. An unidentified correspondent asked that their name remain on file and contemplated use if he were no longer around. The redacted identity and the authority actually granted are unresolved.

The May 2016 correspondence documents requests involving Fisch, New York Cryobank, Karyna Shuliak and deposit paperwork. The deposit packet supplies the administrative framework. The signed May 9 contract documents Epstein’s agreement. Subsequent clinic communication adds to the paper trail. Together they establish a substantial storage arrangement, rather than an isolated mention of sperm banking.

The death disposition form has Option B marked, providing for release through the estate’s legal representative after death. The immediate discard option is not marked. The form also contains conditions under which material could be destroyed if arrangements were not made. It does not establish perpetual preservation or prove that material was ultimately released.

The contract language accommodates specimens supplied by a client or another person. That generic wording does not demonstrate that someone else’s sperm was deposited under Epstein’s arrangement. The shipping terms describe a contractual process without establishing a completed shipment. The payment authorization records a financial arrangement but provides neither an inventory nor proof of all subsequent payments.

Futurism’s June 2026 cryobank reporting relayed the owner’s statement that it did not currently hold samples belonging to Epstein. The Yahoo version of that report concerns the same missing custody history rather than a second discovery. The statement does not identify whether samples were destroyed, transferred, used or classified differently. The present record does not establish surviving viable sperm, an embryo made from it or a resulting child.

Genetics, His Own Genome and Biological Legacy

Harvard’s official review documents a $6.5 million gift in 2003 to establish the Program for Evolutionary Dynamics and more than 40 visits to its offices between 2010 and 2018. It demonstrates a sustained relationship with scientific institutions. Evolutionary research funding alone does not establish a reproductive project or implicate researchers in such a project.

The September 2013 genome correspondence is more personal. Epstein asked for an update on his genome. Lesley Groff forwarded Joseph Thakuria’s report that Epstein’s skin biopsy had produced viable fibroblast cultures stored in liquid nitrogen and slated for induced pluripotent stem cell work. Genome sequencing was also being arranged. This is concrete evidence of interest in his own biological material.

Thakuria’s February 10, 2014 letter supplies an important status check: work on Epstein’s samples was, to his knowledge, on indefinite hold with the Personal Genome Project. He described interests in sequencing, analysis and storage, and functional manipulation of Epstein’s own cell lines. The later proposal still offered induced pluripotent stem cell generation as future work. The 2013 plan therefore cannot establish that those cells had already been generated.

The June 2014 sequencing correspondence discusses sequencing saliva and fibroblast samples, a $2,000 payment arrangement and additional whole genome work. A related approval chain records Epstein agreeing to proposed work. Culturing cells and sequencing DNA do not establish creation of gametes, reproductive cloning, embryo transfer or childbirth.

The June 24, 2014 itemized proposal goes further than sequencing. Thakuria offered to generate induced pluripotent stem cell lines from Epstein’s fibroblasts, maintain samples, reanalyze genomic data and use CRISPR/Cas9 to introduce cell culture mutations expected to increase longevity. It also proposed $160,000 in bioinformatics infrastructure for a Venus project, the YPO study and other research. Selecting every item would have cost $193,400.

The accompanying correspondence and check distinguish the offer from actual expenditure: Thakuria described other items as optional, Epstein instructed staff to send $2,000, and a June 24 check records that amount for sequencing. The larger figure was an optional package, not a paid bill for cloning. The cell editing proposal belongs in the history; this packet does not establish completion of the editing, creation of gametes or an embryo.

The July 2019 New York Times investigation reported that Epstein discussed having women inseminated with his sperm at Zorro Ranch. Sources described ambitions to propagate his DNA. The account of 20 women at once came through Jaron Lanier’s recollection of another scientist’s comments, rather than 20 identified pregnancies. The investigation also described his interest in preserving his head and penis through cryonics. It found no evidence that the reproductive scheme had been implemented. The copy preserved in the released files is a news clipping, so its inclusion adds a retrievable record of the reporting rather than government corroboration of the allegations.

“Obsessed with genetics” is an interpretation of this sustained pattern. The stronger factual formulation is that he pursued genetics and his own genome, while associates reported ambitions to extend his genetic legacy. Ordinary desire for parenthood, preservation of biological options and a grandiose population project are different possibilities. The records do not permit them to be collapsed into one proven motive.

The December 2025 News24 article repeats the earlier New York Times investigation. It explicitly says there is no proof the plan was implemented. It adds coverage of the reported ambition, without supplying independent evidence of pregnancies or children born through it.

Livemint’s February 2026 baby ranch account likewise retells the 2019 investigation. Its headline says the idea was never implemented, while its body uses the narrower formulation that there is no evidence it was carried out. The evidence supports the narrower conclusion. Repeated coverage of a reported ambition cannot establish a pregnancy.

The November 18, 2011 cloning exchange shows Epstein asking George Church whether a cloning issue had given him pause. Church discussed minimizing risks to the field and avoiding the damage caused by rushing work. Epstein’s reply characterized the topic as intellectually amusing and offered not to mention it if Church attended. The discussion predates the skin biopsy record but identifies no cloning subject, embryo or completed procedure.

Southern Trust’s economic development certificate described a DNA database and internet data mining platform, including financial and biomedical informatics. Novamente’s February 4, 2015 invoice billed the company $30,000 for software to analyze gene expression and SNP data, with installation and training. Kahn’s accompanying question asked whether to pay immediately or wait for servers. A Southern Trust asset ledger records a $30,000 software wire to Novamente on April 13, 2015. The records provide a concrete software paper trail, though the ledger does not print the invoice number. They establish neither a reproductive experiment nor a connection to the later Bishop proposal.

The 2018 Designer Baby and Cloning Proposal

The most concrete move from biological curiosity toward a reproductive venture appears in the summer of 2018. This was a specific funding conversation with goals, a budget and legal concerns, rather than another recollection of dinner table talk.

Bryan Bishop’s July 21, 2018 exchange included a designer baby presentation and questions about secrecy, reputation, financing and feasible results. Epstein replied that he had “no issue with investing” but worried about being seen to lead. Bishop’s response the next day discussed anonymity for a potential investor, parents and children. Its conditional language did not describe a completed investment.

The designer babies calendar invitation scheduled a call with Bishop for August 2, 2018, with an agenda covering finance, privacy, goals, outcomes and timelines. The invitation establishes a scheduled appointment, not independently confirmed attendance. The August 5 funding request supplied what Bishop called the requested use of funds for a designer baby and human cloning company. He estimated approximately $1.7 million annually plus $1 million to establish a laboratory, or about $9.5 million over five years. His stated objective was a live designer baby birth and possibly a human clone within that period. Epstein answered, “no rush.”

Bishop’s August 30 update reported mouse surgeries and microinjection at what he called his Ukraine laboratory, alongside an amateur’s human sperm modification tests in Mississippi that did not yet meet his purposes. Epstein’s preceding reply welcomed the imagined endpoint of embryo implantation followed by a nine month wait. The October correspondence records Epstein asking for legal analysis before proceeding and Bishop discussing possible overseas clinic partnerships and sales of DNA material to clinics.

These records establish sustained engagement with a specific proposal and reports of experimental work. They leave the most consequential steps unproved: an Epstein funding transfer, use of his sperm, an implanted human embryo, a cloned person or a birth. The venture’s proposed timetable cannot be turned into an achieved result.

The Center for Genetics and Society’s February 2026 entry presents an excerpt from Émile P. Torres’s critical essay. The original Truthdig essay places the Bishop exchange in a broader interpretation of transhumanism and power. That interpretation provides context, while the correspondence supplies the evidence for what was actually proposed.

The June 8, 2017 genetics order documents another activity that should be kept distinct: 30 23andMe Health + Ancestry kits costing $6,084.95, billed to Epstein. The order and staff exchange connect the kits to Sultan Binsulayem and planned transport to JFK for a Dubai flight. A July 12 registration instruction directed staff to register a kit under the name “rashid epstein” and send it onward through a contact Sultan would identify. The July 31 follow up still described waiting for the contact. These records show procurement and instructions, not a paternity testing program, 30 identified sample donors or reproductive selection.

The July 11, 2017 cancellation exchange supplies an essential qualification: staff reported that 23andMe had invalidated all kits sent to Sultan in Dubai and refunded the payment because of geographic restrictions. The subsequent registration instruction therefore followed the cancellation. An order for genetic testing cannot be treated as a completed set of analyses.

Fertility Treatment for Indyke, Groff and Kahn

Darren Indyke’s account in the Florida biographical submission, at stamps EFTA02857470 and EFTA02857471, says Indyke learned that he was infertile shortly after beginning work for Epstein. This is Indyke’s infertility, not Epstein’s.

Indyke described Epstein as visibly affected by the news, offering to pay treatment bills, researching specialists and providing encouragement through failed treatment and pregnancy loss. His account describes donor eggs and adoption being explored, assistance from Maxwell, and twins after a fifth treatment cycle. Epstein became their godfather. This is unusually detailed testimony about financial and emotional involvement, but it was submitted in a favorable presentation of Epstein rather than as an independently audited medical or payment history.

The July 2007 Lefcourt letter likewise used employee fertility assistance as character evidence. Repetition across defense submissions does not create separate proof of every expenditure.

Lesley Groff’s character letter describes Epstein helping maintain insurance with fertility coverage and offering to fund repeated IVF attempts. Her account supports another instance of assistance, with the same need to acknowledge the favorable purpose of the letter.

Richard Kahn’s June 2009 message thanks Epstein for support with IVF that resulted in a son. Kahn says three embryos remained frozen and discusses another attempt. Epstein forwarded the message with a remark expressing apparent disbelief. The quoted correspondence establishes Kahn’s gratitude and their fertility related communication; it does not identify Epstein as the sperm donor or biological father.

These materials support the proposition that Epstein was familiar with the expense, uncertainty and emotional strain of treatment. They do not establish that he understood those experiences because he himself could not father children. Empathy, loyalty, patronage, control and reputation management remain possible interpretations of different interactions.

Mark Fisher’s December 18, 2009 email adds a distinct example of fertility preservation. Fisher told Epstein that the first expenditure from his financial generosity would be a sperm bank deposit before chemotherapy, including the visit and long term storage charges. The message describes an intended use of assistance, rather than a receipt confirming a completed deposit. It concerns Fisher’s reproductive future, not a deposit of Epstein’s sperm.

Egg Freezing, Hormones and Retrieval Discussions

An August 2012 email records Epstein saying he had been reading about IVF and wanted a discussion before the recipient began hormones. The reply says the recipient was arranging an appointment with a doctor Eva had recommended. The recipient is redacted. This cannot establish a pregnancy involving Eva Andersson Dubin or Epstein’s paternity.

The March 2016 egg freezing correspondence refers to a visit to Zev Rosenwaks concerning egg freezing. The May 2016 message records another expression of interest in freezing eggs. Redacted senders cannot automatically be treated as the same woman.

The December 2017 exchange with Nadia requests a doctor recommendation, with Epstein suggesting Rosenwaks. The March 2018 exchange concerns Extend Fertility, a planned start to treatment and his offer to pay.

A related message has Epstein asking what could be offered in return. Another exchange contains a correspondent’s joking offer of a firstborn. The firstborn remark belongs to the correspondent, not to Epstein. The messages warrant examination of transactional expectations without establishing an agreement to give him a baby.

The April 2018 hormone message reports beginning egg freezing hormones and experiencing a migraine. The subsequent surgery discussion anticipates egg retrieval that weekend. These communications are evidence of treatment being discussed and reported. They are not a retrieval certificate, laboratory inventory or proof that eggs were fertilized using his sperm.

The September 2016 menstrual message describes a first period after hormones without specifying the treatment. It should not be retroactively labeled IVF, pregnancy or abortion. The March 8, 2016 Rosenwaks message was sent to Epstein and Shuliak by a redacted correspondent and mentions an attached image. The one page document does not display the image. It therefore cannot by itself establish what any photographed tubes contained.

The August 8, 2018 “egg people” scheduling request is genuine but unexplained. The August 9 itinerary places a 7:30 a.m. appointment with David Mitchell and the “egg people” on the calendar. A later exchange refers to “egg guys” and jokes about scrambling them without identifying the business. The checked records do not connect these people to Bishop, egg donors or embryo work. Similar dates and suggestive shorthand are insufficient to combine separate meetings into a reproductive operation.

Karyna Shuliak and the Limits of the Record

The March 2017 purchase record documents a YO home sperm testing kit ordered in Karyna Shuliak’s name. The accompanying product email provides additional context for the purchase. Together they show access to a fertility related product. No result or identity of the person whose sample was to be tested is established.

The Cornell reproductive questionnaire is blank. Its presence cannot establish that Shuliak completed a clinical evaluation, underwent IVF or delivered a child. Her involvement in sperm banking logistics likewise does not prove reproductive use.

The forwarded childbirth account concerns another woman’s delivery. Shuliak’s reaction to it is not an account of her own childbirth. Affectionate references to “baby Jeffrey” in exchanges about cats and domestic life also do not independently identify a child.

No verified pregnancy, delivery or biological child of Shuliak and Epstein has been identified in the records reviewed.

Lisa Tait’s July 2026 investigation draws together Shuliak’s role in prescriptions, clinic enquiries, sperm bank forms and the home testing kit. This practical coordination is relevant to the custody and treatment timeline. It does not identify a pregnancy or make an administrator the mother of a supposed child.

The February 19, 2014 email headed “Our baby!” is resolved by its follow up. The February 20 reply quotes “Happy dog!” and makes the animal context explicit. The May 12, 2017 childbirth exchange concerns Epstein forwarding Joi Ito’s account of his partner’s delivery to Shuliak. Neither exchange is evidence that Shuliak delivered Epstein’s child.

The document containing a discussion of doulas is another misleading search hit. At stamp EFTA01721403, it is a general massage textbook passage explaining the role of a doula. It supplies no appointment, patient, pregnancy or birth associated with Epstein.

Requests to Bear His Child and Allegations About Eggs

Johanna Sjoberg’s May 2016 deposition, printed page 40 at stamp EFTA02792185, records her saying Epstein asked more than once whether she wanted to be the mother of his baby. She did not agree. This is sworn evidence of reported requests, without a resulting pregnancy or child.

Virginia Giuffre’s published account preserved in the files describes being asked to have his child and surrender parental rights. Her account connects the demand with the period before she escaped in Thailand in 2002. The preserved article is reporting of her account, not itself a sworn deposition. Epstein’s 2011 correspondence denies the child demand. The competing accounts should remain visible.

Juliette Bryant’s July 2026 interview describes being conscious but incapacitated on a table and her belief that a procedure removed eggs. Her recollection and concern deserve accurate attribution. No operative report, fertility clinic record or independently verified egg retrieval has been identified here.

The December 2025 podcast discussion of Audra Lynn has host Shaun Attwood recounting her allegation of a large financial offer for eggs that she refused. This is a reported offer, relayed in an interview discussion. It must not be described as a completed retrieval or assigned the evidentiary status of a medical record.

The women’s accounts describe different alleged conduct. Requests to carry a baby, offers to buy eggs, suspected nonconsensual procedures and consensual egg freezing cannot be merged into a single demonstrated egg harvesting program. Nor does the evidence presently establish how many women underwent any such procedure.

Fatherhood Claims, DNA Testing and the Paternity Case Record

Record or proceedingWhat it saysWhat remains unresolved
FBI witness interview, August 2019A witness recalled Epstein calling a woman in a beach photograph the mother of his childIdentity, pregnancy, birth and paternity are unverified.
Prison intake, July 2019Epstein stated he had no childrenThis is his own account, not a genetic investigation.
August 2009 emailSomeone was instructed to take a paternity test to New YorkWho was tested and why are not established.
December 2009 laboratory reportThe tested alleged father was excludedSample identities and chain of custody were not verified.
September 2011 congratulations messageSarah Ferguson’s message refers to a baby boyForwarding and recipient context prevent a reliable attribution of fatherhood to Epstein.
Doe v. Black and related settlement proceedingsA claimant alleged Epstein fathered four childrenAllegations are unverified; important supporting material was found falsified.
Estate genealogy inquiriesNumerous people reportedly sought evaluation as possible offspringInquiries are not proven children or successful court paternity cases.

The FBI interview report, at stamp EFTA01246326, records a witness recalling that Epstein pointed to a blonde woman in a beach photograph and called her the mother of his child. The interview took place August 1, 2019. A later administrative date on the record should not be confused with the interview date. The recollection establishes an alleged claim by Epstein, not a verified child.

The July 8, 2019 prison psychology intake records his statement that he was single and had no children. That contradicts the reported fatherhood claim, but does not determine which account, if either, accurately reflected his biological history.

The August 20, 2018 endocrine surgery consultation provides an earlier medical history entry: “Children: None,” at stamp EFTA00314236. It is relevant because it predates his final detention, but a medical history is still not an independent investigation of parentage. It should be weighed beside the conflicting witness recollection, not treated as proof that a child could not exist.

The August 2009 paternity instruction directs someone to take a test to New York. The December test forwarding message is a separate record. They should not be assumed to concern the same test.

The Beta Genetics report gives a combined paternity index of zero, a zero percent probability of paternity and excludes the tested alleged father. Identifying information is redacted. The identifiers “20” and “M-30” are sample labels, not established ages. Crucially, the laboratory states that neutral collection and strict chain of custody were absent, it could not verify sample origins, and the result might not be defensible in court. The report cannot reliably be described as Epstein’s negative paternity result. Even an authenticated exclusion concerning one child would not resolve his fertility or the paternity of any other child.

The September 2011 congratulations chain begins “F writes:” before quoting Sarah Ferguson’s congratulations on a baby boy. The companion forwarding message adds a second quoted passage and preserves reply context associated with the forwarding correspondent. David Stern’s September 4 email tells Epstein about an imminent birth. Stern’s October 1 birth announcement reports that his son was born on September 20. These contemporary records strongly support a forwarding explanation for the congratulations, rather than a direct message congratulating Epstein on fathering a son. They should not be counted as independent evidence of his paternity.

A February 2017 note includes a cryptic reference to surreptitious paternity among financial and other notes. It identifies no child or completed test. A July 2009 exchange discusses another person’s uncertainty about their own biological father. Neither should be presented as a confession of Epstein’s fatherhood.

Not every item in this record is a legal paternity case. No authenticated court determination establishing Epstein as a child’s biological father has been identified in this review.

The Civil Claim of Four Children and the 2026 Court Findings

Sri Lanka Guardian’s February 3, 2026 report brought together claims about secret children, a newborn allegedly removed after delivery, the Ferguson message and Maxwell’s reported sample planning. It acknowledged that the child allegation was unverified and supplied no linked original EFTA records. Its publication preceded the important April ruling below. A reported newborn removal remains an allegation, not an established birth or paternity finding.

The April 23, 2026 opinion in Doe v. Black records an anonymous plaintiff’s testimony in related proceedings alleging that Epstein fathered four of her five children, with births in 2004, 2005, 2006 and 2010. That is a recorded allegation, not a judicial paternity finding.

Judge Jessica G. L. Clarke found that three sonograms in the plaintiff’s journals were falsified: images from a known 2006 pregnancy had been presented as evidence of earlier pregnancies. The court did not find clear and convincing evidence that the other ten sonograms were fraudulent and declined to conclude that the journals as a whole were fabricated.

The court nevertheless sanctioned the plaintiff and her former lawyers, excluded the affected journals and provided for an adverse jury instruction. The order declined to terminate the lawsuit against Leon Black. It neither established Epstein’s paternity nor decided whether Black committed the alleged assault. The distinction matters: the four child allegation cannot be reported without the evidence findings, but those findings cannot be expanded into a ruling that every allegation or every journal was false.

Could He Have Had Children Overseas?

The 2020 reporting on estate genealogy inquiries described approximately 130 potential claimants, including people in Britain, contacting a genealogy firm. The firm said it had not developed sufficient confidence to pursue court DNA testing. These were inquiries, not 130 established children or 130 filed paternity cases.

InsideHook’s account also relayed claims involving France, the Caribbean and the United States. Overseas claims deserve the same verification standards as domestic ones: reliable identity, dates, birth documentation and DNA evidence with an appropriate chain of custody.

His international travel and residences make overseas parenthood possible in the ordinary sense that the reviewed record does not rule it out. Geography alone supplies no evidence of a particular child. No verified overseas offspring has been identified here.

The same standard applies to speculation about the Dubin family. A past relationship with Eva Andersson Dubin, closeness to her family or reported attention to her daughter does not establish biological paternity. No supporting paternity evidence was identified in this review.

Morse Genealogical Services’ heir search notice solicits contact from people who believe Epstein may have been their father or their child’s father and discusses DNA testing as a possible investigative step. It announces no authenticated child, completed positive test or judicial finding. The continuing existence of an invitation for claims does not establish the outcome of any claim.

Mental Health, Masculinity and Resentment Toward Women

The prison intake assessment records Epstein denying a mental health history and current symptoms, with an initially low mental health care classification. It is a brief assessment containing clerical inconsistencies, not a comprehensive lifetime psychiatric evaluation. It neither establishes a personality disorder nor excludes concealed distress.

The undated profile manuscript, including stamp EFTA01132589, attributes remarks to Epstein emphasizing sex, freedom and avoidance of marital burdens. These suggest a self presentation centered on independence. They do not establish that he never wanted children or could not have them. The manuscript is not equivalent to a verified clinical interview.

Several interpretations deserve consideration, with their limits stated clearly:

InterpretationSupporting materialLimit
Reproductive legacy mattered to himGenome work, sperm storage and reported plans to propagate his DNADoes not establish a completed reproductive program.
Treatment threatened his preferred image of his body or competenceComplaints about body changes and impaired thinkingNo direct admission of shame about infertility.
Parenthood could function as a tool of controlMaxwell’s reported promise and Giuffre’s account of relinquishing rightsParticular accounts require attribution; no single motive is proved.
Fertility assistance could express concern for othersIndyke’s detailed account and other treatment supportHis own infertility is not established as the source of concern.
Sexual or reproductive difficulties intensified resentment of womenAnatomical descriptions and hormone history provide questions to investigateNo direct causal statement, chronology or clinical assessment establishes this.

The hypothesis that reproductive frustration contributed to misogyny is possible but unsupported as a conclusion. A causal case would require evidence of his beliefs about women, a documented reproductive setback and a demonstrable change in attitudes or conduct afterward. The available files establish abusive conduct and reproductive interests far more clearly than they establish why those interests developed.

“Narcissistic injury,” “ego death” and clinical narcissistic personality disorder should not be used interchangeably. None is established here as a diagnosis or explanation of his reproductive history. Fertility problems or unusual anatomy do not predict sexual abuse and do not lessen responsibility for it.

The Butterfly Bureau’s September 2026 analysis considers reproductive control within Epstein’s wider pursuit of power and legacy. It is a related interpretation rather than independent medical evidence. The pattern warrants a connected account, but the individual activities still require separate proof: helping an employee conceive, storing one’s own cells, making a coercive reproductive demand and discussing engineered children are not interchangeable acts.

How to Use the Aima Medical Analysis

The March 2026 Aima article is a secondary medical interpretation rather than a substitute for the underlying records. It does not identify the EFTA laboratory documents behind its assertion that testosterone remained below 150 for at least ten years. The documented 2010 value of 188 conflicts with that blanket claim.

Its discussion of possible causes of low testosterone should not be converted into diagnoses of Epstein. Nor should low testosterone be treated as an overlooked condition when his correspondence already records awareness and treatment discussions. Its claims can generate research questions, but each factual assertion needs a traceable original record.

MedPage Today’s coverage belongs in the medical reporting trail. For the numerical and diagnostic claims in this article, the dated laboratory sheets and attributed physician correspondence remain the evidentiary basis. They show recurrent low values alongside within range results and treatment related changes, a more variable history than the assertion that every level remained below 150.

Questions the Remaining Investigation Should Answer

  1. Can a complete semen analysis be identified with reliable patient attribution, dates, concentration, motility and a physician’s interpretation?
  2. What were the actual dates, doses and duration of testosterone and clomiphene treatment? Were sperm measurements obtained before, during or afterward?
  3. Was a vasectomy ever performed, and is there a surgical report or subsequent clearance test?
  4. What did the cryobank receive, how many specimens existed, and what happened to them after death? Can inventories, disposal records or release instructions establish this?
  5. What became of his skin cell cultures and genome data? Can biological storage records be distinguished from reproductive applications?
  6. Who supplied the samples in the 2009 paternity report, and is there an authenticated report connecting them to Epstein?
  7. Do any fatherhood allegations have verified birth records, contemporaneous medical documentation, support payments or reliable DNA evidence?
  8. Can survivors’ egg procurement allegations be corroborated through clinic, anesthesia, procedure, payment or laboratory records without exposing their private identities?
  9. Can consent and ownership be established for eggs or embryos discussed in the files? Were any fertilized using Epstein’s sperm?
  10. Is there direct correspondence connecting reproductive concerns to resentment, humiliation, grief or his treatment of women, rather than retrospective inference?
  11. Can funding records, executed agreements or laboratory records establish whether the 2018 Bishop proposal advanced beyond correspondence?
  12. What was the purpose and final use of the 30 ancestry and health kits, and can it be established without identifying private sample donors?
  13. Can the unexplained “egg people” shorthand be resolved without assuming that every use of “egg” refers to reproductive medicine?

Sources and Reading Notes

EFTA numbers identify released records. A page stamp inside a larger PDF is not necessarily a separately downloadable document. Duplicate records, quoted email chains and repeated witness accounts are not independent corroboration. News clippings within government files remain journalism; their inclusion is not a government finding that every reported allegation is true.

Released records

Reporting, court findings and medical context

Tags:
Previous Jeffrey Epstein’s Health: Medical Records, Diagnoses, Sexual Health, Fertility, and Final Jail Records
Next Medical Evidence in the Jeffrey Epstein Files
Table of Contents